Vertex Pharmaceuticals
Bryan Fenichel is a finance professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as a Senior Finance Manager in Research and Development at Vertex Pharmaceuticals since September 2025, Bryan previously held various finance roles at Neurocrine Biosciences from September 2020 to October 2025, including Finance Business Partner and Senior Financial Analyst. Prior to that, Bryan worked as a Senior Financial Analyst at Portola Pharmaceuticals and was part of the team during its acquisition by Alexion/AstraZeneca in May 2020. Bryan's earlier experience includes positions at BDO USA, LLP as a Senior R&D Tax Associate, and roles at SF Police Credit Union and Wells Fargo. Bryan holds a Bachelor’s Degree in Finance from San Francisco State University, earned in 2015.
This person is not in any teams
This person is not in any offices